Radiation Absorbed Doses per Unit Administered Activity from Intravenous Administration of 90Y-Ibritumomab Tiuxetan
| Target organ | mGy/MBq |
|---|---|
| Adrenals | 0.379 ± 0.118 |
| Brain | 0.379 ± 0.118 |
| Breasts | 0.379 ± 0.118 |
| Gallbladder wall | 0.379 ± 0.118 |
| Lower large intestine | 0.379 ± 0.118 |
| Small intestine | 0.379 ± 0.118 |
| Stomach wall | 0.379 ± 0.118 |
| Upper large intestine wall | 0.379 ± 0.118 |
| Heart wall | 1.08 ± 0.394 |
| Kidneys | 2.44 ± 0.610 |
| Liver | 3.64 ± 1.389 |
| Lungs | 0.761 ± 0.488 |
| Muscle | 0.379 ± 0.118 |
| Ovaries | 0.379 ± 0.118 |
| Pancreas | 0.379 ± 0.118 |
| Red marrow | 2.73 ± 0.909 |
| Osteogenic cells* | 2.14 ± 0.519 |
| Skin | 0.379 ± 0.118 |
| Spleen | 4.65 ± 2.327 |
| Testes | 2.16 ± 0.842 |
| Thymus | 0.379 ± 0.118 |
| Thyroid | 0.379 ± 0.118 |
| Urinary bladder wall | 0.379 ± 0.118 |
| Uterus | 0.379 ± 0.118 |
| Total Body | 0.587 ± 0.107 |
↵* Bone surfaces.
Data are mean ± SD. Three significant figures do not imply precision of 1 in 1,000.